Endocrinology of Cardiovascular Function

  • Ellis R. Levin
  • Jerry L. Nadler

Part of the Endocrine Updates book series (ENDO, volume 1)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Sex Hormone And Vasculature

    1. Front Matter
      Pages 1-1
    2. Anjali K. Morey, Ellis R. Levin
      Pages 25-44
    3. Yiu-Fai Chen, Suzanne Oparil
      Pages 45-59
  3. Angiotensin

    1. Front Matter
      Pages 61-61
    2. Rama Natarajan, Jerry Nadler
      Pages 63-77
    3. Kathy K. Griendling, David G. Harrison
      Pages 79-98
    4. Stéphanie Miserey, Sophie Conchon, Charles Parnot, Colette Auzan, Catherine Monnot, Pierre Corvol et al.
      Pages 99-117
  4. Natriuretic Peptides

    1. Front Matter
      Pages 119-119
    2. Eric A. Espiner, A. Mark Richards, M. Gary Nicholls
      Pages 121-135
  5. Diabetes and Vascular Disease

  6. Endothelin

    1. Front Matter
      Pages 197-197
    2. Eliot H. Ohlstein, John D. Elliott, David P. Brooks
      Pages 199-222
  7. Growth Factors and Vascular Disease

    1. Front Matter
      Pages 223-223
    2. Ping H. Wang
      Pages 225-234
  8. PTHRP in Vasculature

    1. Front Matter
      Pages 235-235
  9. Adrenomedullin: Vascular Hormone

    1. Front Matter
      Pages 255-255
    2. Willis K. Samson
      Pages 257-278
  10. Hypertension

  11. Back Matter
    Pages 339-347

About this book


Endocrinology of Cardiovascular Function is a fitting inauguration to the Endocrine Update Series. The aim of these publications is to provide the clinician with cutting edge, yet succinct, access to the latest advances in endocrinology. Historically, our understanding of hormonal disturbances was restricted to the classical secretory glands and their targets. As Endocrinology of Cardiovascular Function so aptly indicates, endocrinology is no longer constrained by our early physiologic understanding of glandular disorder. Endocrinology of Cardiovascular Function has set the standard of excellence for the future volumes in this series.
Shlomo Melmed, M.D. Series Editor, Endocrine Update
Growth factors such as IGF-1 play important roles in cardiovascular cell hypertrophy and the response to acute vascular injury. From another perspective, traditional endocrine hormones, such as estrogen, have been found to participate in preventing the development of atherosclerosis in women, acting through novel mechanisms on target vascular cells. Other `endocrine' hormones, such as PTHRP and adrenomedullin, also modulate cardiovascular and renovascular dynamic states, suggesting new roles for these peptides as vasodilators. This multi-authored text is dedicated to highlighting emerging and important new information regarding the endocrinology of the cardiovascular system.
Ellis R. Levin, M.D.


Angiotensin II Diabetes cardiovascular cardiovascular function estrogen receptor growth factor hypertension insulin insulin-like steroids

Editors and affiliations

  • Ellis R. Levin
    • 1
  • Jerry L. Nadler
    • 2
  1. 1.DVA Medical Center and University of CaliforniaIrvineUSA
  2. 2.City of Hope Medical CenterDuarteUSA

Bibliographic information

  • DOI
  • Copyright Information Kluwer Academic Publishers 1998
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-7547-0
  • Online ISBN 978-1-4615-5569-8
  • Series Print ISSN 1566-0729
  • Buy this book on publisher's site